Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer
The Pharmacogenomics Journal, Published online: 27 May 2019; doi:10.1038/s41397-019-0089-xCost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 27, 2019 Category: Drugs & Pharmacology Authors: Malek B. Hannouf Gregory S. Zaric Phillip Blanchette Christine Brezden-Masley Mike Paulden Christopher McCabe Jacques Raphael Muriel Brackstone Source Type: research

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s diseaseGenetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease, Published online: 02 May 2019; doi:10.1038/s41397-019-0090-4Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 2, 2019 Category: Drugs & Pharmacology Authors: Adri à Aterido N úria Palau Eugeni Dom ènech Pilar Nos Mateu Ana Guti érrez Fernando Gomoll ón Juan L. Mendoza Esther Garcia-Planella Manuel Barreiro-de Acosta Fernando Mu ñoz Maribel Vera Cristina Saro Maria Esteve Montserrat Andreu Mar ía Chaparr Source Type: research

Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid, Published online: 17 April 2019; doi:10.1038/s41397-019-0086-0Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 17, 2019 Category: Drugs & Pharmacology Authors: Laneshia K. Tague Derek E. Byers Ramsey Hachem Daniel Kreisel Alexander S. Krupnick Hrishikesh S. Kulkarni Catherine Chen Howard J. Huang Andrew Gelman Source Type: research

A genome-wide association study of tramadol metabolism from post-mortem samples
A genome-wide association study of tramadol metabolism from post-mortem samples, Published online: 11 April 2019; doi:10.1038/s41397-019-0088-yA genome-wide association study of tramadol metabolism from post-mortem samples (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 11, 2019 Category: Drugs & Pharmacology Authors: Frank R. Wendt Anna-Liina Rahikainen Jonathan L. King Antti Sajantila Bruce Budowle Source Type: research

Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis
Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis, Published online: 11 April 2019; doi:10.1038/s41397-019-0085-1Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 11, 2019 Category: Drugs & Pharmacology Authors: Jae-Jung Kim Sin Weon Yun Jeong Jin Yu Kyung Lim Yoon Kyung-Yil Lee Hong-Ryang Kil Gi Beom Kim Myung-Ki Han Min Seob Song Hyoung Doo Lee Kee Soo Ha Sejung Sohn Ryota Ebata Hiromichi Hamada Hiroyuki Suzuki Kaoru Ito Yoshihiro Onouchi Young Mi Hong Gi Young Source Type: research

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer, Published online: 10 April 2019; doi:10.1038/s41397-019-0087-zPrognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 10, 2019 Category: Drugs & Pharmacology Authors: Harriet Johansson Valentina Aristarco Sara Gandini Jennifer Gjerde Debora Macis Aliana Guerrieri-Gonzaga Davide Serrano Matteo Lazzeroni Agnita Rajasekaran Clark V Williard Gunnar Mellgren Andrea DeCensi Bernardo Bonanni Source Type: research

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsCorrection: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients, Published online: 14 February 2019; doi:10.1038/s41397-019-0084-2Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 14, 2019 Category: Drugs & Pharmacology Authors: Luz M. Canet Jose M. S ánchez-Maldonado Rafael C áliz Ana Rodr íguez-Ramos Carmen B. Lupia ñez Helena Canh ão Manuel Mart ínez-Bueno Alejandro Escudero Juana Segura-Catena Signe B. Sorensen Merete L. Hetland Mar ía José Soto-Pino Miguel A. Ferrer Source Type: research

Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits
Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits, Published online: 14 February 2019; doi:10.1038/s41397-019-0074-4Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 14, 2019 Category: Drugs & Pharmacology Authors: Jin Li Zhi Wei Jie Zhang Hakon Hakonarson Scott D. Cook-Sather Source Type: research

Precision dosing of warfarin: open questions and strategies
Precision dosing of warfarin: open questions and strategies, Published online: 12 February 2019; doi:10.1038/s41397-019-0083-3Precision dosing of warfarin: open questions and strategies (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 12, 2019 Category: Drugs & Pharmacology Authors: Xi Li Dan Li Ji-Chu Wu Zhao-Qian Liu Hong-Hao Zhou Ji-Ye Yin Source Type: research

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients, Published online: 06 February 2019; doi:10.1038/s41397-019-0077-1DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Marzia Del Re Saverio Cinieri Angela Michelucci Stefano Salvadori Fotios Loupakis Marta Schirripa Chiara Cremolini Stefania Crucitta Cecilia Barbara Angelo Di Leo Tiziana Pia Latiano Filippo Pietrantonio Samantha Di Donato Paolo Simi Alessandro Passardi F Source Type: research

Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia, Published online: 06 February 2019; doi:10.1038/s41397-019-0081-5Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Idoia Martin-Guerrero Angela Gutierrez-Camino Aizpea Echebarria-Barona Itziar Astigarraga Nagore Garcia de Andoin Aurora Navajas Africa Garcia-Orad Source Type: research

Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose, Published online: 06 February 2019; doi:10.1038/s41397-019-0080-6Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Aurelia Viglione Flavia Chiarotti Silvia Poggini Alessandro Giuliani Igor Branchi Source Type: research

Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation, Published online: 06 February 2019; doi:10.1038/s41397-019-0082-4Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Santiago Cuevas Van Anthony M. Villar Pedro A. Jose Source Type: research

Patient-provider communications about pharmacogenomic results increase patient recall of medication changes
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes, Published online: 11 February 2019; doi:10.1038/s41397-019-0076-2Patient-provider communications about pharmacogenomic results increase patient recall of medication changes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Brittany A. Borden Sang Mee Lee Keith Danahey Paige Galecki Linda Patrick-Miller Mark Siegler Matthew J. Sorrentino Yasmin Sacro Andrew M. Davis David T. Rubin Kristen Lipstreuer Tamar S. Polonsky Rita Nanda William R. Harper Jay L. Koyner Deborah L. Burn Source Type: research

Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors, Published online: 04 February 2019; doi:10.1038/s41397-019-0079-zGenetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Michiel C. Verboom Jacqueline S. L. Kloth Jesse J. Swen Stefan Sleijfer Anna K. L. Reyners Neeltje Steeghs Ron H. J. Mathijssen Hans Gelderblom Henk-Jan Guchelaar Source Type: research

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?, Published online: 04 February 2019; doi:10.1038/s41397-019-0078-0Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Federico Nichetti Felicia Stefania Falvella Rosalba Miceli Stefania Cheli Raffaella Gaetano Giovanni Fuc à Gabriele Infante Antonia Martinetti Carlotta Antoniotti Alfredo Falcone Maria Di Bartolomeo Chiara Cremolini Filippo de Braud Filippo Pietrantonio Source Type: research

Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP
Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP, Published online: 31 January 2019; doi:10.1038/s41397-019-0067-3Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 31, 2019 Category: Drugs & Pharmacology Authors: Eleanor M. Wigmore Jonathan D. Hafferty Lynsey S. Hall David M. Howard Toni-Kim Clarke Chiara Fabbri Cathryn M. Lewis Rudolf Uher Lauren B. Navrady Mark J. Adams Yanni Zeng Archie Campbell Jude Gibson Pippa A. Thomson Caroline Hayward Blair H. Smith Lynne Source Type: research

Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib, Published online: 28 January 2019; doi:10.1038/s41397-019-0075-3Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 28, 2019 Category: Drugs & Pharmacology Authors: Marta Schirripa Beatrice Borelli Romina D ’Aurizio Simone Lubrano Chiara Cremolini Gemma Zucchelli Carlotta Antoniotti Federica Marmorino Alessandra Anna Prete Sabina Murgioni Francesca Bergamo Vittorina Zagonel Andrea Tuccoli Andrea Marranci Milena Riz Source Type: research

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab, Published online: 18 January 2019; doi:10.1038/s41397-019-0073-5Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 18, 2019 Category: Drugs & Pharmacology Authors: T. Magnes T. Melchardt C. Hufnagl L. Weiss C. Mittermair D. Neureiter E. Klieser G. Rinnerthaler S. Roesch A. Gaggl R. Greil A. Egle Source Type: research

Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure, Published online: 17 January 2019; doi:10.1038/s41397-019-0068-2Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 17, 2019 Category: Drugs & Pharmacology Authors: Peter R. Hansen Karl Emil Nelveg-Kristensen Henrik B. Rasmussen Christian Torp-Pedersen Lars K øber Claus Henrik Nielsen Christian Enevold Source Type: research

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients, Published online: 17 January 2019; doi:10.1038/s41397-019-0071-7The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 17, 2019 Category: Drugs & Pharmacology Authors: Sarah Allegra Jessica Cusato Silvia De Francia Filomena Longo Elisa Pirro Davide Massano Valeria Avataneo Amedeo De Nicol ò Antonio Piga Antonio D ’Avolio Source Type: research

A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients, Published online: 16 January 2019; doi:10.1038/s41397-019-0072-6A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: C écile Luxembourger Adeline Ruyssen-Witrand Chayma Ladhari C écile Rittore Yannick Degboe Jean-Francis Maillefert Philippe Gaudin Hubert Marotte Daniel Wendling Christian Jorgensen Alain Cantagrel Arnaud Constantin Delphine Nigon Isabelle Touitou Jacqu Source Type: research

Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention, Published online: 16 January 2019; doi:10.1038/s41397-019-0069-1Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Vasilios Fragoulakis Marina Bartsakoulia Xando D íaz-Villamarín Konstantina Chalikiopoulou Konstantina Kehagia Jes ús Gabriel Sánchez Ramos Luis Javier Mart ínez-González Maria Gkotsi Eva Katrali Efthimios Skoufas Athanassios Vozikis Anne John Bassa Source Type: research

Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective studyWarfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study, Published online: 16 January 2019; doi:10.1038/s41397-019-0066-4Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Tereza Ruzickova Martin Sramek Vojtech Kaplan Simona Kumstyrova Zuzana Lacinova Petr Jansky Hana Magerova Ivana Sarbochova Jaroslava Paulasova Schwabova Vaclav Matoska Ales Tomek Source Type: research

An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care, Published online: 16 January 2019; doi:10.1038/s41397-019-0070-8An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Reinier L. Sluiter Joost G. E. Janzing Gert Jan van der Wilt Wietske Kievit Martina Teichert Source Type: research

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing, Published online: 16 November 2018; doi:10.1038/s41397-018-0063-zIdentification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 16, 2018 Category: Drugs & Pharmacology Authors: Casey R. Dorr Baolin Wu Rory P. Remmel Amutha Muthusamy David P. Schladt Juan E. Abrahante Weihua Guan Roslyn B. Mannon Arthur J. Matas William S. Oetting Pamala A. Jacobson Ajay K. Israni Arthur J. Matas J. Michael Cecka John E. Connett Fernando G. Cosio Source Type: research

Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?, Published online: 08 November 2018; doi:10.1038/s41397-018-0064-yTenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 8, 2018 Category: Drugs & Pharmacology Authors: A. Calcagno M. Fiuman ò D. Zugna J. Cusato C. Montrucchio L. Marinaro L. Trentini M. Ferrara A. D ’Avolio C. Pizzi G. Di Perri S. Bonora Source Type: research

Iatrogenic hypertension: a bioinformatic analysis
Iatrogenic hypertension: a bioinformatic analysis, Published online: 05 November 2018; doi:10.1038/s41397-018-0062-0Iatrogenic hypertension: a bioinformatic analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 5, 2018 Category: Drugs & Pharmacology Authors: Alon Botzer Yoram Finkelstein Ehud Grossman John Moult Ron Unger Source Type: research

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorderReplication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder, Published online: 27 October 2018; doi:10.1038/s41397-018-0065-xReplication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 27, 2018 Category: Drugs & Pharmacology Authors: Richard C. Crist Karran A. Phillips Melody A. Furnari Landhing M. Moran Glenn A. Doyle Laura F. McNicholas James W. Cornish Kyle M. Kampman Kenzie L. Preston Wade H. Berrettini Source Type: research

Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients, Published online: 15 October 2018; doi:10.1038/s41397-018-0061-1Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 15, 2018 Category: Drugs & Pharmacology Authors: Shuhui Si Zijie Wang Haiwei Yang Zhijian Han Jun Tao Hao Chen Ke Wang Miao Guo Ruoyun Tan Ji-Fu Wei Min Gu Source Type: research

Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs
Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs, Published online: 08 October 2018; doi:10.1038/s41397-018-0058-9Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 8, 2018 Category: Drugs & Pharmacology Authors: Michal Walczak Marzena Skrzypczak-Zielinska Marianna Plucinska Oliwia Zakerska-Banaszak Daria Marszalek Liliana Lykowska-Szuber Kamila Stawczyk-Eder Agnieszka Dobrowolska Ryszard Slomski Source Type: research

Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort
Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort, Published online: 05 October 2018; doi:10.1038/s41397-018-0056-yPharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 5, 2018 Category: Drugs & Pharmacology Authors: Ricardo Pinto Joana Assis Augusto Nogueira Carina Pereira Sara Coelho Mariana Brand ão Jo ão Dias Sara Alves Deolinda Pereira Rui Medeiros Source Type: research

Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density
Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density, Published online: 05 October 2018; doi:10.1038/s41397-018-0059-8Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 5, 2018 Category: Drugs & Pharmacology Authors: W.-J. Wang W.-Z. Fu J.-W. He C. Wang Z.-L. Zhang Source Type: research

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients, Published online: 05 October 2018; doi:10.1038/s41397-018-0057-xPolymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 5, 2018 Category: Drugs & Pharmacology Authors: Luz M. Canet Jose M. S ánchez-Maldonado Rafael C áliz Ana Rodr íguez Ramos Carmen B. Lupia ñez Helena Canh ão Manuel Mart ínez-Bueno Alejandro Escudero Juana Segura-Catena Signe B Sorensen Merete L Hetland Mar ía José Soto-Pino Miguel A. Ferrer An Source Type: research

Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci
Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci, Published online: 27 September 2018; doi:10.1038/s41397-018-0055-zGenome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 27, 2018 Category: Drugs & Pharmacology Authors: Xingbo Mo Shufeng Lei Yonghong Zhang Huan Zhang Source Type: research

Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis
Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis, Published online: 24 September 2018; doi:10.1038/s41397-018-0054-0Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 24, 2018 Category: Drugs & Pharmacology Authors: Qian Xiang Shu-qing Chen Ling-yue Ma Kun Hu Zhuo Zhang Guang-yan Mu Qiu-fen Xie Xiao-dan Zhang Yi-min Cui Source Type: research

Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults, Published online: 24 September 2018; doi:10.1038/s41397-018-0053-1Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 24, 2018 Category: Drugs & Pharmacology Authors: Sze Ling Chan Hong Yen Ng Cynthia Sung Alexandre Chan Michael D Winther Liam R Brunham Hwee-Lin Wee Source Type: research

Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis
Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis, Published online: 21 September 2018; doi:10.1038/s41397-018-0052-2Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 21, 2018 Category: Drugs & Pharmacology Authors: Wimonchat Tangamornsuksan Manupat Lohitnavy Source Type: research

Genetic markers in methotrexate treatments
Genetic markers in methotrexate treatments, Published online: 20 September 2018; doi:10.1038/s41397-018-0047-zGenetic markers in methotrexate treatments (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 20, 2018 Category: Drugs & Pharmacology Authors: Andrea Giletti Patricia Esperon Source Type: research

HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions
HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions, Published online: 20 September 2018; doi:10.1038/s41397-018-0051-3HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 20, 2018 Category: Drugs & Pharmacology Authors: Sijia Yan Hao Xiong Fengmin Shao Wen Zhang Fanping Yang Zheng Qi Shengan Chen Lin He Menglin Jiang Yu Su Huizhong Zhu Shengying Qin Qinyuan Zhu Xiaoqun Luo Qinghe Xing Source Type: research

Genome-wide association analysis of common genetic variants of resistant hypertension
Genome-wide association analysis of common genetic variants of resistant hypertension, Published online: 20 September 2018; doi:10.1038/s41397-018-0049-xGenome-wide association analysis of common genetic variants of resistant hypertension (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 20, 2018 Category: Drugs & Pharmacology Authors: Nihal El Rouby Caitrin W. McDonough Yan Gong Leslie A. McClure Braxton D. Mitchell Richard B. Horenstein Robert L. Talbert Dana C. Crawford Matthew A. Gitzendanner Atsushi Takahashi Toshihiro Tanaka Michiaki Kubo Carl J. Pepine Rhonda M. Cooper-DeHoff Osc Source Type: research

An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor, Published online: 20 September 2018; doi:10.1038/s41397-018-0050-4An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 20, 2018 Category: Drugs & Pharmacology Authors: Gloria Ravegnini Milena Urbini Vittorio Simeon Chiara Genovese Annalisa Astolfi Margherita Nannini Lidia Gatto Maristella Saponara Manuela Ianni Valentina Indio Giovanni Brandi Stefania Trino Patrizia Hrelia Guido Biasco Sabrina Angelini Maria A. Pantaleo Source Type: research

Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes, Published online: 14 September 2018; doi:10.1038/s41397-018-0048-yWhole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 14, 2018 Category: Drugs & Pharmacology Authors: Jihoon Choi Kelan G. Tantisira Qing Ling Duan Source Type: research

Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism
Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism, Published online: 12 September 2018; doi:10.1038/s41397-018-0045-1Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 12, 2018 Category: Drugs & Pharmacology Authors: S ètondji Cocou Modeste Alexandre Yahouédéhou Elis ângela Vitória Adorno Caroline Concei ção da Guarda Uche Samuel Ndidi Suellen Pinheiro Carvalho Rayra Pereira Santiago Milena Magalh ães Aleluia Rodrigo Mota de Oliveira Marilda de Souza Gon çalv Source Type: research

A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma, Published online: 12 September 2018; doi:10.1038/s41397-018-0042-4A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 12, 2018 Category: Drugs & Pharmacology Authors: Melissa L. Spear Donglei Hu Maria Pino-Yanes Scott Huntsman Celeste Eng Albert M. Levin Victor E. Ortega Marquitta J. White Meghan E. McGarry Neeta Thakur Joshua Galanter Angel C. Y. Mak Sam S. Oh Elizabeth Ampleford Stephen P. Peters Adam Davis Rajesh Ku Source Type: research

An optimized prediction framework to assess the functional impact of pharmacogenetic variants
An optimized prediction framework to assess the functional impact of pharmacogenetic variants, Published online: 12 September 2018; doi:10.1038/s41397-018-0044-2An optimized prediction framework to assess the functional impact of pharmacogenetic variants (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 12, 2018 Category: Drugs & Pharmacology Authors: Yitian Zhou Souren Mkrtchian Masaki Kumondai Masahiro Hiratsuka Volker M. Lauschke Source Type: research

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies
Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies, Published online: 12 September 2018; doi:10.1038/s41397-018-0043-3Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 12, 2018 Category: Drugs & Pharmacology Authors: Katherine M. Robinson Wenjian Yang Cyrine E. Haidar Jane S. Hankins Dennis W. Jay Nancy Kornegay Jeffrey E. Rubnitz Ulrich Broeckel Cheng Cheng Ching-Hon Pui Sima Jeha Mary V. Relling Source Type: research

Race and precision medicine: is it time for an upgrade?
Race and precision medicine: is it time for an upgrade?, Published online: 10 September 2018; doi:10.1038/s41397-018-0046-0Race and precision medicine: is it time for an upgrade? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 10, 2018 Category: Drugs & Pharmacology Authors: Youssef M. Roman Source Type: research

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art
Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art, Published online: 07 September 2018; doi:10.1038/s41397-018-0029-1Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 7, 2018 Category: Drugs & Pharmacology Authors: Weronika Maria Szejniuk Ana I. Robles Tine McCulloch Ursula Gerda Inge Falkmer Oluf Dimitri R øe Source Type: research

BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis
BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis, Published online: 05 September 2018; doi:10.1038/s41397-018-0041-5BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 5, 2018 Category: Drugs & Pharmacology Authors: Eric Huang Nuwan C. Hettige Gwyneth Zai Julia Tomasi Justin Huang Clement C. Zai Nela Pivac Matea Nikolac Perkovic Arun K. Tiwari James L. Kennedy Source Type: research